Cargando…
Metformin-induced activation of AMPK inhibits the proliferation and migration of human aortic smooth muscle cells through upregulation of p53 and IFI16
The proliferation and migration of vascular smooth muscle cells are significant in the development and progression of atherosclerosis and plaque rupture. Metformin is a widely used antidiabetic drug, which has been reported to inhibit cell growth and migration. The antiproliferative and antimigrator...
Autores principales: | Hao, Biao, Xiao, Yan, Song, Fang, Long, Xiangshu, Huang, Jing, Tian, Maobo, Deng, Shiyan, Wu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819901/ https://www.ncbi.nlm.nih.gov/pubmed/29286156 http://dx.doi.org/10.3892/ijmm.2017.3346 |
Ejemplares similares
-
Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis
por: You, Ganhua, et al.
Publicado: (2020) -
Long Noncoding RNA EZR-AS1 Regulates the Proliferation, Migration, and Apoptosis of Human Venous Endothelial Cells via SMYD3
por: You, Ganhua, et al.
Publicado: (2020) -
IFI16 Induction by Glucose Restriction in Human Fibroblasts Contributes to Autophagy through Activation of the ATM/AMPK/p53 Pathway
por: Duan, Xin, et al.
Publicado: (2011) -
Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration
por: Zhou, Dong-Ming, et al.
Publicado: (2020) -
Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans
por: Stadion, Mandy, et al.
Publicado: (2018)